Double maintains 1 strategies that include SANA - Sana Biotechnology, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VIR | 73.62% | $706.40M | -42.26% | 0.00% |
ANGO | 57.23% | $386.58M | +68.20% | 0.00% |
CPRX | 47.72% | $2.58B | +34.11% | 0.00% |
COLL | 41.52% | $973.91M | -5.43% | 0.00% |
MATW | 40.72% | $762.50M | -0.08% | 4.02% |
EBAY | 38.69% | $35.08B | +42.91% | 1.48% |
AIR | 31.95% | $2.51B | -3.58% | 0.00% |
CALX | 26.92% | $3.40B | +53.27% | 0.00% |
ROKU | 26.62% | $12.64B | +40.48% | 0.00% |
NRIX | 26.58% | $892.72M | -38.14% | 0.00% |
ADTN | 26.18% | $731.50M | +78.17% | 0.00% |
PACB | 26.17% | $387.11M | +0.78% | 0.00% |
CXT | 26.03% | $3.18B | -6.93% | 1.19% |
CRSP | 25.98% | $4.19B | -8.67% | 0.00% |
MSM | 25.81% | $5.03B | +12.87% | 3.83% |
AYI | 25.79% | $9.39B | +25.77% | 0.21% |
LFVN | 25.73% | $168.56M | +113.90% | 1.24% |
OPFI | 25.50% | $1.18B | +297.99% | 0.00% |
MTH | 25.13% | $5.10B | -8.17% | 3.32% |
EYPT | 25.02% | $657.15M | +19.23% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCEL | -25.55% | $130.92M | -33.12% | 0.00% |
EIX | -22.39% | $20.35B | -26.18% | 6.12% |
IONQ | -18.31% | $10.49B | +461.62% | 0.00% |
KR | -12.79% | $47.17B | +41.48% | 1.81% |
JNJ | -12.59% | $375.15B | +6.77% | 3.23% |
SYPR | -12.22% | $46.42M | +9.19% | 0.00% |
LPTH | -12.19% | $129.55M | +117.27% | 0.00% |
VSTA | -11.71% | $341.66M | +42.00% | 0.00% |
CWT | -11.28% | $2.77B | -3.70% | 2.49% |
RELL | -9.79% | $139.08M | -16.89% | 2.45% |
CWEN | -9.38% | $3.72B | +30.90% | 5.44% |
MBI | -9.26% | $220.63M | -15.61% | 0.00% |
CWEN.A | -9.19% | $3.52B | +33.89% | 5.74% |
KRP | -8.99% | $1.30B | -15.91% | 12.13% |
CBOE | -8.85% | $24.29B | +35.36% | 1.09% |
DG | -8.74% | $25.37B | -10.94% | 2.05% |
T | -8.59% | $207.81B | +53.45% | 3.83% |
EDN | -8.49% | $578.85M | +73.61% | 0.00% |
ATOM | -8.39% | $152.29M | +28.50% | 0.00% |
KLG | -8.37% | $1.47B | +3.58% | 3.74% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QNRX | 0.01% | $5.43M | -54.36% | 0.00% |
CNP | -0.01% | $23.84B | +19.89% | 2.34% |
DTE | -0.05% | $27.48B | +21.05% | 3.27% |
ELS | 0.05% | $11.82B | -3.35% | 3.20% |
IEP | 0.05% | $4.54B | -49.65% | 30.23% |
INMD | 0.08% | $1.03B | -14.82% | 0.00% |
SOHU | -0.09% | $405.28M | -3.09% | 0.00% |
WDS | -0.10% | $29.52B | -20.44% | 7.82% |
SWX | 0.10% | $5.41B | +6.23% | 3.32% |
BKH | 0.10% | $4.12B | +4.59% | 4.70% |
BTU | 0.11% | $1.60B | -43.87% | 2.15% |
PCRX | -0.12% | $1.08B | +2.24% | 0.00% |
EIG | 0.15% | $1.14B | +9.92% | 2.57% |
ULS | -0.15% | $13.98B | +63.03% | 0.74% |
SUNS | 0.15% | $144.15M | -4.96% | 11.42% |
SNN | 0.17% | $13.39B | +23.99% | 2.50% |
BCE | 0.17% | $20.86B | -27.77% | 10.84% |
KO | 0.18% | $308.49B | +13.49% | 2.78% |
CLRB | 0.19% | $8.81M | -93.19% | 0.00% |
CASI | 0.20% | $20.61M | -75.42% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 33.01% | $44.38M | 0.5% |
PBE | 29.25% | $223.86M | 0.58% |
ARKG | 29.09% | $1.02B | 0.75% |
XBI | 26.61% | $4.84B | 0.35% |
FBT | 25.50% | $1.01B | 0.54% |
XHB | 24.27% | $1.34B | 0.35% |
SMLF | 23.26% | $1.81B | 0.15% |
ONLN | 23.21% | $77.55M | 0.58% |
IBB | 23.11% | $5.28B | 0.45% |
XSMO | 22.99% | $1.68B | 0.39% |
PTH | 22.96% | $100.70M | 0.6% |
IJT | 22.90% | $6.06B | 0.18% |
SLYG | 22.79% | $3.40B | 0.15% |
XMHQ | 22.47% | $4.97B | 0.25% |
PRFZ | 22.46% | $2.36B | 0.34% |
GRPM | 22.28% | $454.92M | 0.35% |
IJK | 22.26% | $8.84B | 0.17% |
MDYG | 22.23% | $2.26B | 0.15% |
JMEE | 22.21% | $1.84B | 0.24% |
ITB | 22.04% | $2.16B | 0.39% |
Finnhub
Sana Biotechnology, Inc. added to Russell 3000 Value Index...
Finnhub
Sana Biotechnology, Inc. added to Russell 2500 Value Index...
Finnhub
Sana Biotechnology, Inc. added to Russell Small Cap Comp Value Index...
Finnhub
Sana Biotechnology, Inc. added to Russell 2000 Value Index...
Finnhub
Sana Biotechnology, Inc. added to Russell 3000E Value Index...
Yahoo
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company’s stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic […]
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMP | -22.54% | $553.36M | 0.18% |
BTAL | -21.34% | $295.67M | 1.43% |
VIXY | -17.57% | $165.58M | 0.85% |
TAIL | -16.09% | $99.49M | 0.59% |
KCCA | -12.23% | $105.90M | 0.87% |
BSMW | -11.79% | $107.29M | 0.18% |
FXY | -11.45% | $820.31M | 0.4% |
WIP | -11.21% | $382.35M | 0.5% |
XHLF | -11.09% | $1.73B | 0.03% |
UDN | -9.53% | $147.49M | 0.78% |
FXB | -9.29% | $92.39M | 0.4% |
ULST | -8.97% | $658.54M | 0.2% |
BUXX | -8.94% | $324.81M | 0.25% |
SHYM | -8.91% | $354.58M | 0.35% |
CTA | -8.71% | $1.06B | 0.76% |
MLN | -8.61% | $540.39M | 0.24% |
KRBN | -8.60% | $162.64M | 0.85% |
BWX | -8.30% | $1.53B | 0.35% |
SPTS | -7.96% | $5.77B | 0.03% |
DFNM | -7.85% | $1.57B | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HTRB | 0.02% | $2.02B | 0.29% |
BIV | 0.03% | $23.30B | 0.03% |
FLCB | 0.04% | $2.59B | 0.15% |
GCOR | -0.08% | $586.96M | 0.08% |
VGLT | 0.08% | $9.76B | 0.04% |
CLOA | -0.11% | $918.81M | 0.2% |
AGG | 0.12% | $128.76B | 0.03% |
SCHP | 0.14% | $12.99B | 0.03% |
VCSH | 0.15% | $34.34B | 0.03% |
EAGG | -0.16% | $3.98B | 0.1% |
SPAB | -0.20% | $8.79B | 0.03% |
EMBD | 0.21% | $229.12M | 0.39% |
BND | -0.22% | $130.90B | 0.03% |
IDU | -0.30% | $1.42B | 0.39% |
PWZ | -0.31% | $748.91M | 0.28% |
GVI | -0.32% | $3.41B | 0.2% |
FXU | -0.33% | $1.65B | 0.64% |
GOVZ | -0.34% | $267.77M | 0.1% |
SPTL | 0.34% | $11.23B | 0.03% |
NUAG | -0.34% | $58.63M | 0.19% |
Current Value
$2.831 Year Return
Current Value
$2.831 Year Return